Liverpool Cancer Therapy Centre

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Colorectal cancer1 trial
• Lung cancer1 trial

Phase

• Phase 1/21 trial
• Phase 21 trial

Status

• Not yet recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Anbogen Therapeutics, Inc.1 trial
• BioNTech SE1 trial

Running trials

• Recruiting

  A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC

  NCT07244705· Phase 1/2· Anbogen Therapeutics, Inc.· Source

  Contact: Ryan Hua

• Recruiting

  Safety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line Treatment

  NCT06841055· Phase 2· BioNTech SE· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer1 recruiting
• Lung cancer1 recruiting